Treatment with STG320 Sublingual Tablets of House Dust Mite Allergen Extracts: Profile of Subjects with HDM-Associated Allergic Rhinitis in the Clinical Development Program

Rationale Efficacy and safety of STG320 house dust mite (HDM) sublingual tablets for the treatment of HDM-associated allergic rhinitis (AR) have been assessed in 7 DBPC clinical trials.

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 137; no. 2; p. AB163
Main Authors Bergmann, Karl-Christian, Demoly, Pascal M., Roux, Michel, Khairallah, Sandrine, Zeldin, Robert K.
Format Journal Article
LanguageEnglish
Published St. Louis Elsevier Inc 01.02.2016
Elsevier Limited
Subjects
Allergies
Allergy and Immunology
Asthma
Online AccessGet full text

Cover

More Information
Summary:Rationale Efficacy and safety of STG320 house dust mite (HDM) sublingual tablets for the treatment of HDM-associated allergic rhinitis (AR) have been assessed in 7 DBPC clinical trials.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2015.12.665